Efficacy and safety of switching to dolutegravir/lamivudine by baseline regimen in virologically suppressed adults: 48-week pooled analysisStefan Scholten,Pedro Cahn,Peter Ruane,Richard Kaplan,Joaquin Portilla,Sally Hodder,Fiona Bisshop,Brian R. Wynne,Richard Grove, Gilda Bontempo, Riya Moodley,Bryn Jones,Mounir Ait-Khaled,Chinyere Okoli, Harald FetscherHIV MEDICINE(2023)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要